Medical Aesthetics Business Consulting
| US & EU Growth Strategy
We partner with ambitious medical aesthetics companies to unlock growth, create market-defining categories, and drive enterprise value across the US and Europe.
Founded by Benoit Chardon, a proven category creator in medical aesthetics, BCC is a high impact consulting collective that transforms emerging brands into market leaders through strategic growth consulting and hands-on advisory.
Trusted by industry disruptors worldwide
Our Consulting Business in Numbers
Fully qualified physician database enabling more efficient prospecting.
Why Medical Aesthetics Leaders Choose BCC
More than a business consultant. I'm a builder, proven category creator, and growth strategist specializing in medical aesthetics, weight loss, women health and wellness innovation.
With 25+ years launching and scaling aesthetic medicine brands across US and European markets, I help ambitious companies create new categories, expand internationally, and dominate aesthetic, longevity and wellness sectors through strategic B2B2C and DTC cash-pay go-to-market models. Trusted by CEOs and PE partners - see 25 recommendations on LinkedIn.
Benoit’s Way of working:
- Results focused
- Insights led
- Fearlessly innovative
- Direct and confident to challenge
Our clients trust us
Because we deliver:
- Deep domain expertise
- Track record of speed and scale
- Successful launch & new category creation
$4B+ in exits. 25 years of impact.
Filorga™
(skincare)
Acquired by Colgate for $1.4B
Galderma™
(Medical Aesthetics)
Grew revenue from $100M to $700M
CoolSculpting™
(Capital Equipment)
Acquired by Allergan for $2,5B
Allurion™
(weight loss)
100% CAGR for 5 years – $0,5B IPO (NYSE)”
Fastox™
(early-stage botulinum toxin)
Acquired by AbbVie
Medical Aesthetics Business Consulting: Disrupter. Creator. Shaper.
We embed as an extension of your medical aesthetics leadership team - diving deep into market data to uncover growth opportunities in aesthetic medicine, weight loss, women's health and wellness, moving fast, thinking boldly, and delivering results where others don't.
Strategy that’s grounded in data, not guesswork
Perspective shaped by 25+ years of global commercial success stories
Flexible model: board-level counsel, fractional CCO, special ops, commercial due diligence
Shaping Market Leaders
Medical Aesthetics, Weight Loss,
Women's Health and Wellness.
Global Commercial Performance
We unlock untapped growth in medical aesthetics by aligning your commercial strategy with industry best practices and performance levers.
From B2B2C campaigns, and aesthetic practice development to internal team activation, and HCP education in aesthetic medicine, we drive long-term competitive advantage for medical aesthetics companies, which now expands to weight loss, women's health and wellness.
- Data-driven business reviews
- Commercial policies & incentive plans
- Leadership motivation & sales team engagement
- HCP trial & organic patient education programs
- Practice development coaching
- B2B inside sales + omnichannel campaign
New Category Creation & Launch Planning
Through sharp positioning, go-to-market strategy, and storytelling, we turn disruptive medical aesthetics innovations into market-defining brands.
Supported by our medical aesthetics network of KOLs, investors, and top talent, we help aesthetic medicine companies create new categories and commercial momentum.
- Consumer insights & TAM definition
- Positioning, Branding, segmented USPs
- High reach HCP qualification
- Database of 100k+ HCPs including 50k+ USA leads
- Go to market & Call point strategy
- B2B2C experience trial with high authority HCPs for organic content creation
- Data driven social media training
Private Equity, Due Diligence
As a former CCO and board member in aesthetic medicine and weight loss companies, Benoit helps shape investor strategy, refine pitch narratives, and unlock M&A/IPO value for medical aesthetics brands.
Drawing on this experience, we support PE firms and founders with medical aesthetics, weight loss, women's health and wellness commercial due diligence, investor storytelling, and exit preparation.
- Commercial audit prior to PE investment
- Benchmark best-in-class organizations
- Board meeting preparation
- Investor presentations
- Fund raising
- Streamline commercial operations pre IPO or M&A
4 models to support your business
We offer four proven models designed to deliver measurable results and long-term impact:
Part-Time CCO/CEO for Medical Aesthetics Startups
- Annual retainer contract, success fees & equity
- Commitment: 1-2 days/week
- Cost: €229k to €458k base
Medical Aesthetics Business Consulting Assignments
- Launch or scale-up with a team of BCC consultants
- Includes annual retainer & success fees
- Cost: €280k to €980k
Commercial Due Diligence for Private Equity
- 3-month audit with BCC consultants
- Cost: €50k to €120k
Board Member & Venture Partner
- Equity + consulting fees as needed
360° coverage
of Medical Aesthetics, Weight loss, Women's Health & Wellness
Open categories
Where we have expertise and welcome new clients
Active clients
We do not add clients competing with out current clients
Current portfolio:
Breast Aesthetics
First minimally invasive breast implants by Establishment Labs
Laser Innovation
Aerolase First skin health laser for all skin types
Regenerative Medicine
Linio Biotech First human-origin heterologous regenerative procedure
Skincare
RoCSkincare #1 retinol anti-aging brand in pharmacy
Food Intolerance
CellTolerance First cellular-level food intolerance test and IBS program
Women’s Health
Natural Cycles First FDA-cleared birth control AI powered app
HA fillers
Confidential assignment: reposition HA fillers after crisis
Fat matrix
Create the new category of structural adipose tissue designed for body contouring
Mental Health
Supporting innovation in behavioural wellness and cognitive health
Body Contouring & Tightening
Breakthroughs in non-invasive reshaping devices
Toxins
Advancing the next generation of aesthetic injectables
Weight Loss
Innovations in medically-backed weight management
Hair Growth
Less invasive / noninvasive procedure to hair regenration
Technology
AI applied to Aesthetics, Wellness or Practice development
RoC Skincare™ (By BridgePoint PE)
Anti-Aging Retinol based skincare (sold in Pharmacies)
Drove Commercial Due Diligence for Acquisition
Supported BridgePoint’s acquisition of RoC with precise brand and commercial potential evaluation
Executed the Largest HCP Skincare Study & B2B2C Campaign
Activated 35 clinics treating 200+ patients to share results organically on social media—achieving 4M+ consumer reach, 3% engagement (3× industry standard), and +200% sell-out after rollout.
Trained HCPs for Social Media Impact
Conducted in-depth audit and delivered hands-on training for French and American HCPs to maximize organic reach & campaign visibility.
Amplified with Influencer & Event Strategy
Extended campaign momentum through earned media, key opinion leaders, and congress activations spotlighting medical outcomes.
Key results post 1-year assignment:
- 35 top HCPs endorse the brand publicly: reach 4M+
- 3x higher than average engagement on HCP posts (3%)
- +200% growth in sell-out 2 quarters after HCP's posts
- RoC Skincare ranked in the top 5 highest growth brands
“We greatly valued Benoit’s ability to seamlessly blend strategic leadership with hands-on execution, which was instrumental in completing a groundbreaking skincare study with over 35 leading French HCPs in record time and outstanding results. This study significantly elevated RoC's profile not only among HCPs, media, and retail partners in France, but also on a global scale.”
Take a look at the RoC Skincare™ B2B2C campaign
Aerolase™
Energy base device / Capital Equipment (Aesthetics & Dermatology)
CEO-Level Growth Partner
Partnered directly with the Founder & CEO to drive company valuation through brand transformation and strategic business development.
Repositioned the Brand
Led a full-market rebrand, establishing Aerolase as the category-defining solution in safe, holistic, and patient-friendly laser treatments.
Inside Sales / B2B Prospecting
Identified and qualified high reach USA Plastics & OBGYN. Direct prospecting to book qualified meetings for the sales team.
Accelerated Global Expansion
Activated strategic introductions and optimized commercial pathways across key international markets.
Enabled Successful Fundraising
Crafted investor-ready narrative and aligned market vision to secure capital and fuel next-stage innovation.
Key results post 1-year assignment:
- +29% revenue growth in Q1 2025 vs 2024 ($52m+ FY for 2025)
- +20% FY EBITA trend in 2025 vs 2024
- 25% cross-selling: account purchasing more than 1 laser (up from 10%)
- +100% international revenue growth (2025 vs 2024)
“Benoit is the definition of an A Player.
His strategic insights and hands-on approach have transformed our brand and elevated our company’s market position for the long run in only 1 year. Working with Aerolase™ team on reimagining our branding / positioning, product design, and accelerating international growth, Benoit has played a key role by selecting and leading top talents and agencies to partner with us in the most cost-effective manner. I enjoy working with Benoit, he is not just a consultant—he’s a true partner in our success”
Take a look at the Aerolase rebranding
CellTolerance™ (by Mauna Kea Technologies)
Food Intolerance–Linked IBS Program | Confocal Laser En domicroscop y | Cash-Pay Innovation
Launched a New Business Unit
Built and scaled the first IBS program focused on food intolerance, enabling cellular-level diagnostics through advanced endomicroscopy.
Designed a Holistic Treatment Model
Developed a multidisciplinary care pathway combining nutrition, psychology, and diagnostics
Activated Market Penetration Strategy
Mapped and engaged high-value USA & Europ call points with a focused stakeholder strategy to accelerate clinical adoption and payer traction.
Positioned as a New Category Creation
Led branding, messaging, and full-funnel collateral to position CellTolerance as a disruptive innovation—fuelling sell-in & sell-out.
Created a success-fee global senior agent network (10 FTEs)
Selected, hired, trained industry veterans to launch the right way.
“Benoit’s outstanding track record in new category creation and hands-on B2B2C approach were critical in bringing the CellTolerance™ program to life. The cash-pay business was new for us and Benoit helped us rethink how we should approach the launch of that new business, chose the right go-to-market model (B2B2C) to best leverage our limited resources, and gear up in less than 9 months to the actual launch with prestigious Medical Aesthetic networks, leveraging his tight relationships with key decisions makers. Benoit is also a solid asset to strengthen our fund-raising activities with a credible presentation of our commercial model.
Thanks to Benoit, CellTolerance™ was elevated from a disruptive clinical discovery to a high potential business. Our new Business Unit can now help patients get to the root of their symptoms and transform partner clinics with a material incremental revenue stream. It’s been a real pleasure to work with Benoit and we very much look forward to seeing him play a bigger role going forward.”
Take a look at the new premium CellTolerance brand
Mia Femtech™ (by Establishment Labs)
New Category of Injectable Breast implants without General Anesthesia (Plastic Surgery)
Accelerated the Launch of Mia
Drove awareness and adoption of the world’s first 15-minute injectable breast enhancement—no surgery, no general anaesthesia.
Built B2B2C Conversion Engines
Developed trade marketing and practice development programs to boost clinic productivity, elevate conversion rates, and scale adoption.
Empower the sales team to audit, correct and grow sell-out
Train the Practice Development Manager team to partnered efficiently with clinic teams to embed Mia’s solution into real-world practices, ensuring commercial and clinical success
Key results post 1-year assignment:
- 140% revenue growth (direct) & better forecasting accuracy
- 251% growth of sell-out procedures vs LY
- 2x lead to purchase conversion rate
- 3x higher productivity on clinics supported by a trained PDM
- USD 10m YTD revenue (International)
Creating a shiny innovation is one thing: reaching commercial success is another. We jointly created a clinic success model that was launched during the first Mia global summit: feedback from the attendees was unanimous “the best meeting they ever attended”. His work on building strong practice development capabilities is boosting our organic reach, conversion rates and making clinics more efficient and productive. Benoit’s approach in 3 words: Pragmatic, Data -driven, Bold.”
Take a look at the Mia practice development training
Natural Cycles™ (by Lauxera PE)
Femtech Innovation | FDA -Approved Digital Birth Control
Secured HCP Endorsements for Sustainable Growth
Built partnerships with top OBGYNs across the U.S. to drive clinical credibility and adoption.
Activated a B2B2C Model to Accelerate Adoption
Enabled HCPs to trial, validate, and publish results—positioning Natural Cycles as a trusted women’s health solution across provider and consumers. Pilot N=30 HCPs, followed by large scale study N=95, with 2500 patients enrolled.
Inside Sales / B2B Prospecting
Recruitment of high reach / high authority USA OBGYN.Direct prospecting to book meetings with CMO.
Data Driven Social Media Training
Collaborated with healthcare professionals to counter misinformation and amplify trust in digital birth control through social media.
Qualified High-Impact Influencers
Mapped the top 1,000 U.S. and 360 Brazil women’s health HCPs, for strategic engagement, with 193M and 166M of total reach, respectively.
“Natural Cycles™ has been extremely successful growing consumer adoption, and we reached a point of our growth where we wanted to partner with women health experts, the OBGYNs, to reach our next stage of growth. But that was totally new for our team. We met Benoit and his team during the commercial due diligence done by our new main shareholder Lauxera Private Equity prior to investing 50m$ in our company : it became obvious that the B2B2C opportunity would be much larger than we thought, and that Benoit and his senior consultants had everything our brand needed to leverage that growth opportunity in an accelerated fashion! I have no doubt that new B2B2C / HCP business unit will transform our organization, brand and the sustainability of our growth. We really appreciate the collaborative and respectful approach of the BCC team which fit perfectly with our culture, focus on delivering results, the right way.”
Take a look at the closing of Natural Cycles financing round
-min%20(1).avif)
A Stellar Crew of Experts & Partners
At BCC™, we know that exceptional results in medical aesthetics stem from exceptional partnerships.
Our global team of senior leaders, top-tier aesthetic medicine consultants, and specialized agency partners has spent over a decade delivering transformative outcomes for medical aesthetics companies.
Together, we help clients achieve, and exceed, their most ambitious business goals in aesthetic medicine.
Our Partners
Authentic Connections Matter
As success is all about people, culture and leadership, I love to foster links between my preferred bosses, investors, clients and team members to enable the Benoit Chardon Consulting™ community to create authentic connections and build the industry power houses of tomorrow. A few times a year we gather at my place in Paris to celebrate long term friendships: the most attended event happens every year the night before the IMCAS conference in Paris.
We create new categories, power up launches, accelerate growth, and fundraise.
We leverage proven talents with a track record of success to position your innovation and scale your business in the most cost-effective way.
Get in contact
This form is reserved for medical aesthetics companies and new clients in weight loss, women's health and wellness only: we don't accept new team member applications as Benoit handpicks top talent from within his aesthetic medicine network based on who he has personally worked with in previous organizations.